Prédispositions héréditaires au cancer du sein : après BRCA1 et BRCA2, quel(s) autre(s) gène(s) ? = Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?BONADONA, Valérie; LASSET, Christine.Bulletin du cancer. 2003, Vol 90, Num 7, pp 587-594, issn 0007-4551, 8 p.Article

Prise en charge des femmes à risque héréditaire de cancer du sein : indications et modalités du dépistage par mammographie = Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screeningLASSET, Christine; BONADONA, Valérie.Bulletin du cancer. 2001, Vol 88, Num 7, pp 677-686, issn 0007-4551Article

ÉTUDES DE COHORTE ET ÉTUDES PRONOSTIQUES = Cohort studies and prognostic studiesMETZGER, Marie-Hélène; LASSET, Christine.La Revue du praticien (Paris). 2009, Vol 59, Num 4, pp 535-538, issn 0035-2640, 4 p.Article

Mésothéliomes familiaux : une composante génétique associée aux risques environnementaux ? = Family mesotheliomas : genetic interaction with environmental carcinogenic exposure?YOU, Benoit; BLANDIN, Sonia; GERINIERE, Laurence et al.Bulletin du cancer. 2007, Vol 94, Num 7-8, pp 705-710, issn 0007-4551, 6 p.Article

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersCOX, David G; SIMARD, Jacques; SZABO, Csilla et al.Human molecular genetics (Print). 2011, Vol 20, Num 23, pp 4732-4747, issn 0964-6906, 16 p.Article

Spontaneous disclosure of BRCA112 genetic test results to employers: a French prospective studyEISINGER, François; FABRE, Roxane; LASSET, Christine et al.European journal of human genetics. 2012, Vol 20, Num 9, pp 981-983, issn 1018-4813, 3 p.Article

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeBONADONA, Valérie; BONAITI, Bernard; COLAS, Chrystelle et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 22, pp 2304-2310, issn 0098-7484, 7 p.Article

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneHUGHES, David J; GINOLHAC, Sophie M; GIRAUD, Sophie et al.International journal of cancer. 2005, Vol 117, Num 2, pp 230-233, issn 0020-7136, 4 p.Article

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsGINOLHAC, Sophie M; GAD, Sophie; MULLER, Danièle et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 2, pp 90-95, issn 1055-9965, 6 p.Article

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testingMANCINI, Julien; NOGUES, Catherine; LASSET, Christine et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 871-881, issn 0959-8049, 11 p.Article

Fiabilité des taux de réponses en oncologie : analyse des causes de variation = Response rate accuracy in oncologyNEGRIER, Sylvie; OLLIVIER, Liliane; DI STEFANO-LOUINEAU, Donatella et al.Bulletin du cancer. 2000, Vol 87, Num 12, pp 927-934, issn 0007-4551Article

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor―negative breast cancer in the general populationANTONIOU, Antonis C; XIANSHU WANG; GHOUSSAINI, Maya et al.Nature genetics. 2010, Vol 42, Num 10, pp 885-892, issn 1061-4036, 8 p.Article

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and reviewBONADONA, Valérie; DUSSART-MOSER, Sophie; RAUDRANT, Daniel et al.Breast cancer research and treatment. 2007, Vol 101, Num 2, pp 233-245, issn 0167-6806, 13 p.Article

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersHUGHES, David J; GINOLHAC, Sophie M; HARDOUIN, Agnès et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 1, pp 265-267, issn 1055-9965, 3 p.Article

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines : a report from the Groupe Français d'immunothérapieNEGRIER, Sylvie; GOMEZ, Frédéric; DOUILLARD, Jean-Yves et al.World journal of urology (Print). 2005, Vol 23, Num 3, pp 161-165, issn 0724-4983, 5 p.Article

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: Prognostic value of interleukin-6-from the groupe français d'immunothérapieNEGRIER, Sylvie; PEROL, David; MENETRIER-CAUX, Christine et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2371-2378, issn 0732-183X, 8 p.Article

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: Reactions and behavior after the disclosure of a positive test resultBONADONA, Valérie; SALTEL, Pierre; PUISIEUX, Alain et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 1, pp 97-104, issn 1055-9965Article

Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypesBOYAULT, Sandrine; DROUET, Youenn; NAVARRO, Claudine et al.Breast cancer research and treatment. 2012, Vol 132, Num 1, pp 29-39, issn 0167-6806, 11 p.Article

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and QuebecDORVAL, Michel; NOGUES, Catherine; BERTHET, Pascaline et al.European journal of human genetics. 2011, Vol 19, Num 5, pp 494-499, issn 1018-4813, 6 p.Article

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation CarriersSPURDLE, Amanda B; MARQUART, Louise; GSCHWANTLER-KAULICH, Daphne et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 5, pp 1032-1038, issn 1055-9965, 7 p.Article

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)LECARPENTIER, Julie; NOGUES, Catherine; GESTA, Paul et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 927-938, issn 0167-6806, 12 p.Article

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study : A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating groupBROHET, Richard M; GOLDGAR, David E; NOGUES, Catherine et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3831-3836, issn 0732-183X, 6 p.Article

Acetyl-CoA carboxylase a gene and breast cancer susceptibilitySINILNIKOVA, Olga M; GINOLHAC, Sophie M; ROMESTAING, Pascale et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 12, pp 2417-2424, issn 0143-3334, 8 p.Article

BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic StrategyANCZUKOW, Olga; BUISSON, Monique; LEONE, Melanie et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4903-4909, issn 1078-0432, 7 p.Article

Estimating cancer risk in HNPCC by the GRL methodALARCONL, Flora; LASSET, Christine; CARAYOL, Jérome et al.European journal of human genetics. 2007, Vol 15, Num 8, pp 831-836, issn 1018-4813, 6 p.Article